And several specific DRD2 agonists like bromocriptine have already used clinically in nervous system disorder 32, 33, and molecular mechanism underlying DRD2 anti-tumor effects might facilitate to breast cancer treatment by using selective DRD2 agonists. This evidence concerns the gene DRD2 and breast carcinoma.